The Digital Therapeutics Alliance has hired Andy Molnar as CEO. He arrives from Cognoa, where he served as VP of market access and government affairs.

“Andy’s deep knowledge of the digital therapeutics industry, his expertise in market access for DTx products and his vision for DTA makes him the ideal CEO to lead us into the future,” said Debra Reisenthel, chair of the DTA board of directors, in a statement.